Skip to results
Modify your search
NARROW
1-20 of 23
Authors: Patrick Neven
Journal Article
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences Open Access
JNCI Cancer Spectrum, Volume 7, Issue 4, August 2023, pkad045, https://doi.org/10.1093/jncics/pkad045
Published: 27 June 2023
Journal Article
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study Free
JNCI: Journal of the National Cancer Institute, Volume 115, Issue 8, August 2023, Pages 998–999, https://doi.org/10.1093/jnci/djad089
Published: 22 May 2023
Journal Article
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets Open Access
Clinical Chemistry, Volume 68, Issue 9, September 2022, Pages 1164–1176, https://doi.org/10.1093/clinchem/hvac095
Published: 29 June 2022
Journal Article
Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations Free
Clinical Chemistry, Volume 66, Issue 11, November 2020, Pages 1414–1423, https://doi.org/10.1093/clinchem/hvaa196
Published: 28 October 2020
Journal Article
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer Free
JNCI: Journal of the National Cancer Institute, Volume 113, Issue 2, February 2021, Pages 146–153, https://doi.org/10.1093/jnci/djaa090
Published: 06 July 2020
Journal Article
A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data Free
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 10, October 2020, Pages 979–988, https://doi.org/10.1093/jnci/djaa050
Published: 07 April 2020
Journal Article
Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy Open Access
The Oncologist, Volume 25, Issue 2, February 2020, Pages e243–e251, https://doi.org/10.1634/theoncologist.2019-0551
Published: 24 October 2019
Journal Article
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor‐Positive, HER‐2 Negative Breast Cancer Free
The Oncologist, Volume 24, Issue 2, February 2019, Pages 165–171, https://doi.org/10.1634/theoncologist.2018-0176
Published: 31 August 2018
Journal Article
Body mass index and breast cancer survival: a Mendelian randomization analysis Open Access
International Journal of Epidemiology, Volume 46, Issue 6, December 2017, Pages 1814–1822, https://doi.org/10.1093/ije/dyx131
Published: 09 October 2017
Journal Article
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers Free
JNCI: Journal of the National Cancer Institute, Volume 108, Issue 2, February 2016, djv315, https://doi.org/10.1093/jnci/djv315
Published: 19 November 2015
Journal Article
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization Free
JNCI: Journal of the National Cancer Institute, Volume 107, Issue 11, November 2015, djv219, https://doi.org/10.1093/jnci/djv219
Published: 20 August 2015
Journal Article
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer Get access
Carcinogenesis, Volume 36, Issue 2, February 2015, Pages 256–271, https://doi.org/10.1093/carcin/bgu326
Published: 13 January 2015
Journal Article
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk Get access
Human Molecular Genetics, Volume 24, Issue 1, 1 January 2015, Pages 285–298, https://doi.org/10.1093/hmg/ddu431
Published: 28 August 2014
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First‐Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer Free
The Oncologist, Volume 19, Issue 4, April 2014, Pages 348–349, https://doi.org/10.1634/theoncologist.2014-0021
Published: 27 March 2014
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer Free
The Oncologist, Volume 19, Issue 4, April 2014, Pages 346–347, https://doi.org/10.1634/theoncologist.2014-0022
Published: 27 March 2014
Journal Article
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency Get access
Carcinogenesis, Volume 33, Issue 7, July 2012, Pages 1319–1326, https://doi.org/10.1093/carcin/bgs187
Published: 23 May 2012
Journal Article
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 6, 21 March 2012, Pages 441–451, https://doi.org/10.1093/jnci/djs125
Published: 06 March 2012
Journal Article
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium Get access
Human Molecular Genetics, Volume 20, Issue 16, 15 August 2011, Pages 3289–3303, https://doi.org/10.1093/hmg/ddr228
Published: 19 May 2011
Journal Article
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 3, 2 February 2011, Pages 250–263, https://doi.org/10.1093/jnci/djq526
Published: 29 December 2010
Journal Article
Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 22, 17 November 2010, Pages 1706–1715, https://doi.org/10.1093/jnci/djq415
Published: 04 November 2010
